RBC Capital raised the firm’s price target on MannKind (MNKD) to $7 from $5 and keeps a Sector Perform rating on the shares. The company reported another strong quarter with total revenues up 37%, continued pull-through of Tyvaso DPI royalty and collaboration revenues, and appreciable Afrezza performance, supporting the topline, the analyst tells investors in a research note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter